We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.09%
3 Consumer Discretionary 12.78%
4 Industrials 12.5%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
1
Genpact
G
$5.3B
$3.62M 0.54%
85,338
+61,400
+256% +$2.6M
RLAY icon
2
Relay Therapeutics
RLAY
$4.02B
$2.99M 0.45%
+178,593
New +$3.83M
EEM icon
3
iShares MSCI Emerging Markets ETF
EEM
$28B
$2.87M 0.43%
+71,463
New +$3M
BF.B icon
4
Brown-Forman Class B
BF.B
$12B
$2.25M 0.34%
+32,026
New +$2.15M
MODV
5
DELISTED
ModivCare
MODV
$2.23M 0.33%
+26,396
New +$2.67M
TECK icon
6
Teck Resources
TECK
$29.5B
$2.23M 0.33%
+72,849
New +$2.87M
CASY icon
7
Casey's General Stores
CASY
$31.9B
$2.21M 0.33%
+11,955
New +$2.41M
AVT icon
8
Avnet
AVT
$7.33B
$2.17M 0.33%
50,659
+31,448
+164% +$1.37M
AVID
9
DELISTED
Avid Technology Inc
AVID
$2.17M 0.33%
+83,537
New +$2.43M
BMY icon
10
Bristol-Myers Squibb
BMY
$127B
$2.15M 0.32%
27,910
+25,005
+861% +$1.9M
OEC icon
11
Orion
OEC
$394M
$2.14M 0.32%
+137,977
New +$2.31M
ITT icon
12
ITT
ITT
$17.5B
$2.12M 0.32%
31,573
+26,214
+489% +$1.87M
IOVA icon
13
Iovance Biotherapeutics
IOVA
$2.23B
$1.97M 0.3%
178,578
+161,755
+962% +$2.12M
PRMW
14
DELISTED
Primo Water Corporation
PRMW
$1.95M 0.29%
145,461
+58,820
+68% +$827K
STAA icon
15
STAAR Surgical
STAA
$1.16B
$1.94M 0.29%
27,327
+17,172
+169% +$1.11M
CMCSA icon
16
Comcast
CMCSA
$79.1B
$1.91M 0.29%
48,755
+41,411
+564% +$1.78M
HAE icon
17
Haemonetics
HAE
$3.58B
$1.9M 0.29%
+29,214
New +$1.73M
SXT icon
18
Sensient Technologies
SXT
$5.4B
$1.9M 0.29%
23,569
+14,536
+161% +$1.21M
HSKA
19
DELISTED
Heska Corp
HSKA
$1.85M 0.28%
+19,583
New +$2.11M
QVCGA
20
DELISTED
QVC Group Inc Series A
QVCGA
$1.83M 0.28%
12,775
+10,792
+544% +$2.1M
MNRO icon
21
Monro
MNRO
$525M
$1.82M 0.27%
+42,357
New +$1.89M
HLF icon
22
Herbalife
HLF
$1.23B
$1.81M 0.27%
+88,573
New +$2.19M
GEF icon
23
Greif
GEF
$4.47B
$1.8M 0.27%
+28,928
New +$1.77M
SLG icon
24
SL Green Realty
SLG
$3.88B
$1.8M 0.27%
+38,931
New +$2.48M
TALO icon
25
Talos Energy
TALO
$2.49B
$1.78M 0.27%
115,207
+46,149
+67% +$898K

Similar funds

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.